Literature DB >> 16402406

The zinc finger protein Gfi1 acts upstream of TNF to attenuate endotoxin-mediated inflammatory responses in the lung.

Jianmin Jin1, Hui Zeng, Kurt-Werner Schmid, Martin Toetsch, Stefan Uhlig, Tarik Möröy.   

Abstract

Gfi1 is a 55-kD nuclear zinc finger protein that is differentially expressed in lymphoid and myeloid cells. Gfi1(-/-) mice show a very strong systemic response to the endotoxin LPS and die rapidly within 36 h with symptoms of septic shock. Here we report that the pathohysiological processes for this exaggerated inflammatory response take place in the lung. After LPS treatment, lungs of Gfi1(-/-) mice showed a rapid accumulation of mononuclear cells and a significant overproduction of inflammatory cytokines such as TNF, IL-1beta and IL-6. Increased cytokine production was also observed in blood-free perfused lungs from Gfi1(-/-) mice exposed to either LPS or overventilation. Alveolar macrophages but not airway epithelial cells from Gfi1(-/-) mice were found to be responsible for the enhanced cytokine production. Strikingly, when the TNF gene was deleted, Gfi1(-/-) animals were completely rescued from LPS hypersensitivity and had significantly lower IL-1beta and IL-6 levels. We conclude that the unrestrained endotoxin response of Gfi1(-/-) mice occurs mainly in the lung and that Gfi1 represents a novel factor limiting the inflammatory immune response of this organ, and propose that Gfi1 exerts its regulatory function in alveolar macrophages downstream of the LPS receptor (TLR4) and upstream of TNF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402406     DOI: 10.1002/eji.200535155

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  GFI-1 Protects Against Lipopolysaccharide-Induced Inflammatory Responses and Apoptosis by Inhibition of the NF-κB/TNF-α Pathway in H9c2 Cells.

Authors:  Yanlei Zheng; Shi Li; Ronghua Hu; Fei Cheng; Li Zhang
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Zinc finger protein Gfi1 controls the endotoxin-mediated Toll-like receptor inflammatory response by antagonizing NF-kappaB p65.

Authors:  Ehssan Sharif-Askari; Lothar Vassen; Christian Kosan; Cyrus Khandanpour; Marie-Claude Gaudreau; Florian Heyd; Taro Okayama; Jianmin Jin; Meghan E B Rojas; H Leighton Grimes; Hui Zeng; Tarik Möröy
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 3.  Zn(2+) at a cellular crossroads.

Authors:  Xiaomeng Liang; Robert E Dempski; Shawn C Burdette
Journal:  Curr Opin Chem Biol       Date:  2016-03-21       Impact factor: 8.822

4.  Zinc finger protein 64 promotes Toll-like receptor-triggered proinflammatory and type I interferon production in macrophages by enhancing p65 subunit activation.

Authors:  Chunmei Wang; Xingguang Liu; Yin Liu; Qian Zhang; Zhenyu Yao; Bo Huang; Peng Zhang; Nan Li; Xuetao Cao
Journal:  J Biol Chem       Date:  2013-07-15       Impact factor: 5.157

5.  Up-regulation of growth factor independence 1 in endotoxin tolerant macrophages with low secretion of TNF-alpha and IL-6.

Authors:  Min-Fang Zhu; Jing Zhang; Jie-Ming Qu; Hui-Jun Zhang; Shuang-Cheng Zhou; Sheng-Fu Dong; Hong-Ni Jiang; Hanssa Summah
Journal:  Inflamm Res       Date:  2010-04-17       Impact factor: 4.575

6.  Role of lung-marginated monocytes in an in vivo mouse model of ventilator-induced lung injury.

Authors:  Michael R Wilson; Kieran P O'Dea; Da Zhang; Alexander D Shearman; Nico van Rooijen; Masao Takata
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

Review 7.  From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation.

Authors:  Tarik Möröy; Lothar Vassen; Brian Wilkes; Cyrus Khandanpour
Journal:  Blood       Date:  2015-10-07       Impact factor: 22.113

Review 8.  Zinc in innate and adaptive tumor immunity.

Authors:  Erica John; Thomas C Laskow; William J Buchser; Bruce R Pitt; Per H Basse; Lisa H Butterfield; Pawel Kalinski; Michael T Lotze
Journal:  J Transl Med       Date:  2010-11-18       Impact factor: 5.531

Review 9.  Myeloma bone disease: Pathophysiology and management.

Authors:  Rebecca Silbermann; G David Roodman
Journal:  J Bone Oncol       Date:  2013-04-18       Impact factor: 4.072

Review 10.  Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling.

Authors:  Fabrizio Accardi; Denise Toscani; Marina Bolzoni; Benedetta Dalla Palma; Franco Aversa; Nicola Giuliani
Journal:  Biomed Res Int       Date:  2015-10-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.